Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans

Objective. Microaneurysms, acellular capillaries, pericyte ghosts, and thickening of retinal capillary basement membrane are characteristic of diabetic retinopathy, and are believed to be sequelae of excessive blood glucose. Previous studies by us in dogs demonstrated that lesions of diabetic retinopathy were not uniformly distributed across the retina, but were significantly more numerous in the superior/temporal areas of the retina. In the present study, the distribution of these lesions and the biochemical abnormalities postulated to play a role in their pathogenesis have been evaluated in retinas collected at autopsy from diabetic patients. Methods. Retinas were divided into quadrants (nasal, temporal, superior, inferior), the vasculature exposed by the trypsin-digest method, and the frequency of the lesions compared among the quadrants. Homogenates taken from the midretina of nasal and temporal quadrants of retina were used to explore regional differences in expression of Glut1, PKCß, and iNOS (Western blots) and caspases (enzymatic activity). Results. Microaneurysms, acellular capillaries and pericyte ghosts were not uniformly distributed across the retina, and were significantly more numerous in the temporal retina than in the nasal retina (P < 0.05). In contrast, the thickness of retinal capillary basement membrane was not found to differ significantly across the retina. In our limited study, activity of the pro-inflammatory protease, caspase 1, was the only biochemical abnormality where there was both a significant diabetes-induced alteration in activity and also a significant difference between retinal quadrants. Expression of the glucose transporter, Glut1, was significanlty decreased in diabetes, but there was no significant difference in expression between the quadrants. Expression of iNOS was increased only in temporal retina in diabetes (but no significant difference between quadrants), and PKCß tended to be greater than normal in both temporal and nasal retina. Conclusions. Retinal microvascular disease does not develop uniformly across the retina of diabetic patients, even though the different regions are exposed to the same level of hyperglycemia.

[1]  M. Lorenzi,et al.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.

[2]  N. Thornberry,et al.  Interleukin‐1βconverting enzyme: A novel cysteine protease required for IL‐1β production and implicated in programmed cell death , 1995, Protein science : a publication of the Protein Society.

[3]  T. Gardner,et al.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.

[4]  G. King,et al.  Biochemical and Molecular Mechanisms in the Development of Diabetic Vascular Complications , 1996, Diabetes.

[5]  C. Kilo,et al.  Estimation of Vascular Basement Membrane Thickness: Theoretical and Practical Considerations , 1969, Diabetes.

[6]  D. Cogan,et al.  Studies of Retinal Vascular Patterns: Part I. Normal Architecture , 1960 .

[7]  K Muraoka,et al.  Distribution of capillary nonperfusion in early-stage diabetic retinopathy. , 1984, Ophthalmology.

[8]  L. Aiello,et al.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Cogan,et al.  Studies of retinal vascular patterns. I. Normal architecture. , 1960, Archives of ophthalmology.

[10]  T. Gardner,et al.  Molecular mechanisms of vascular permeability in diabetic retinopathy. , 1999, Seminars in ophthalmology.

[11]  W. Pardridge,et al.  Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus , 1996, Brain Research.

[12]  T. Kern,et al.  Vascular lesions in diabetes are distributed non-uniformly within the retina. , 1995, Experimental eye research.

[13]  J. Williamson,et al.  Muscle capillary basement-membrane thickness and long-term glycemia in type I diabetes mellitus. , 1984, The New England journal of medicine.

[14]  T. Kern,et al.  Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. , 2001, Investigative ophthalmology & visual science.

[15]  T. Kern,et al.  Subnormal retinal oxygenation response precedes diabetic-like retinopathy. , 1999, Investigative ophthalmology & visual science.

[16]  M. Dubois‐Dauphin,et al.  Acute application of an interleukin‐1β‐converting enzyme‐specific inhibitor delays axotomy‐induced motoneurone death , 1996, Neuroreport.

[17]  R. Engerman,et al.  Epithelial and mesothelial basement membranes in diabetic patients and dogs , 1982, Diabetologia.

[18]  P. Johnson,et al.  Thickened cerebral cortical capillary basement membranes in diabetics. , 1982, Archives of pathology & laboratory medicine.

[19]  M. Davis,et al.  Clinicopathologic correlations in diabetic retinopathy. I. Histology and fluorescein angiography of microaneurysms. , 1976, Archives of ophthalmology.

[20]  L. Kagemann,et al.  Regional differences in optic disc and retinal circulation. , 2000, Acta ophthalmologica Scandinavica.

[21]  F. Ismail-Beigi,et al.  Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. , 2000, Diabetes.

[22]  J. Cunha-Vaz,et al.  Diabetic retinopathy. Human and experimental studies. , 1972, Transactions of the ophthalmological societies of the United Kingdom.

[23]  T. Kern,et al.  Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. , 2001, Diabetes.

[24]  Junying Yuan,et al.  Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta- converting enzyme-mediated apoptosis , 1996, The Journal of experimental medicine.

[25]  N. Farid,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. , 1998, Diabetes.

[26]  S. Mohr,et al.  Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.

[27]  K Muraoka,et al.  Midperipheral fundus involvement in diabetic retinopathy. , 1981, Ophthalmology.

[28]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[29]  L. Kagemann,et al.  Regional differences in retinal vascular reactivity. , 1999, Investigative ophthalmology & visual science.

[30]  M. Lorenzi,et al.  Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. , 2001, Diabetes.

[31]  T. Kern,et al.  Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. , 1993, Diabetes.

[32]  Mark A. Smith,et al.  Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine , 2002, Journal of neurochemistry.

[33]  R. E. Anderson,et al.  Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. , 1992, Investigative ophthalmology & visual science.

[34]  J H Dobree,et al.  Proliferative diabetic retinopathy. Site and size of initial lesions. , 1970, The British journal of ophthalmology.